Abstract:Delayed cerebral ischemia as a result of cerebral vasospasm is the most common cause of death and disability after aneurysmal subarachnoid hemorrhage (SAH). It leads to death or permanent neurologic deficits in over 17-40% of SAH patients. The initial and main symptom of cerebral vasospasm is diffuse headache and may be accompanied with a slight increase in discomfort from neck stiffness and fever. The clinical diagnosis of cerebral vasospasm is made when the patient experiences an altered level of consciousness or a new focal neurologic deficit. There has been a great progress in identifying the patients at risk, putative mechanisms, and possible treatment options for cerebral vasospasm. However, the problem is by no means solved, mainly due to a limited understanding of the pathologic mechanisms of this complex disease. The iatrogenic factors that can increase the risk of cerebral vasospasm include prolongation of the subarachnoid clot by antifibrinolytic drugs, hypotension, inappropriate treatment of hyponatremia, hypovolemia, hyperthermia and increased intracranial pressure. Nimodipine has been shown to improve neurologic outcome and decrease the incidence of cerebral vasospasm. Triple H therapy is a treatment designed to augment cerebral blood flow for patient with cerebral vasospasm. Hypervolemic hypertension is induced with intravenous volume expansion with crystalloid or colloid to increase cardiac output and raise blood pressure. However, small randomized trials showed no clear benefit. Recently, balloon and chemical angioplasty with superselective intra-arterial injection of vasodilators has emerged as the primary intervention for treating medically refractory ischemia from cerebral vasospasm and in many centers is being used as a first-line treatment or even prophylactically. In addition, promising new treatments for cerebral vasospasm or its ischemic complications include magnesium sulfate, fasudil hydrochloride, tirilazad mesylate, erythropoietin, and induced hypothermia; however, all still need further clinical trials. Newly recognized mediators of cerebral vasospasm after SAH include endothelium-derived mediators, vascular smooth-muscle-derived mediators, proinflammatory mediators involved in blood-brain barrier disruption, cytokines and adhesion molecules, stress-induced gene activation, and platelet-derived growth factors. Moreover, observations in the laboratory have, in many circumstances, matched those of reported small series. Larger, prospective, randomized trials are needed to verify several hypotheses of molecular pathophysiology and clinical treatment regimens.

Vasospasm in traumatic brain injury

440 Retrospective Assessment of the Clinical Timeline and Predictors for Vasospasm Severity in Traumatic Brain Injury Within a Safety-Net Hospital Population

Cerebral vasospasm after traumatic brain injury: an update

Cerebral Vasospasm: Practical Review of Diagnosis and Management

Vascular headache an traumatic brain injury

Cerebral Infarction Due to Post-traumatic Cerebral Vasospasm in a 12-Year-Old Female

Traumatic Brain Injury and Traumatic Spinal Cord Injury

Cerebral Venous Thrombosis in Patients With Traumatic Brain Injury: Epidemiology and Outcome

From vasospasm to early brain injury: new frontiers in subarachnoid haemorrhage research

[Neurosurgical Management of Traumatic Brain Injury]

Clinical Significance of Vascular Occlusive Events following Moderate-to-Severe Traumatic Brain Injury: An Observational Cohort Study

Clinical Management in Traumatic Brain Injury

Traumatic brain injury: Symptoms to systems in the 21st century

Treatment of cerebral vasospasm after subarachnoid hemorrhage--a review

Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought

Traumatic Brain Injury and Intracranial Hemorrhage Induced Cerebral Vasospasm and Delayed Cerebral Ischemia in a Patient with a Fall - Significance of the High-Cost Tertiary Investigations in Medico-Legal Practice; a Case Report

Response of the cerebral vasculature following traumatic brain injury

Neurovascular disease, diagnosis, and therapy: Subarachnoid hemorrhage and cerebral vasospasm

Immunological Profile of Vasospasm after Subarachnoid Hemorrhage

Postoperative Cerebral Vasospasm Following Transsphenoidal Pituitary Adenoma Surgery

Cerebral vasospasm after subarachnoid hemorrhage: an update